Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-005235
Filing Date
2023-03-20
Accepted
2023-03-20 17:19:09
Documents
1
Period of Report
2023-01-15

Document Format Files

Seq Description Document Type Size
1 form4-03202023_090303.html 4  
1 form4-03202023_090303.xml 4 14185
  Complete submission text file 0001415889-23-005235.txt   15575
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Moat Ross (Reporting) CIK: 0001857177 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 23747151